Med Special

Trump’s Comeback: What MedTech Needs to Brace For and Capitalize On

From Deregulation to Tax Cuts, Trump’s Policies Could Redefine the MedTech Landscape — But Are Companies Ready?...

AiMeD hails Union Budget-2024; will give a boost to overall economic growth: Rajiv Nath

Medical devices industry was expecting more for quality and affordable healthcare: AiMeD Forum Coordinator Rajiv Nath...

MedTech Industry Surpasses $42 Billion in R&D Investment, Drives Growth Through Strategic M&A Deals

COVID-19 Accelerates Demand for Diagnostics, Fuels Robust Sector Growth; Major Deals by Johnson & Johnson, BD, and Danaher Highlight Expansion and Innovation Strategies....

Urology of Virginia Announces New Chief Executive Officer

Dr. Joshua Langston Assumes Role of Managing Partner and CEO at Urology of Virginia...

NEOM is fundamentally reshaping health by placing a strong emphasis on personalised care

The core of a holistic health reform lies in the integration of emerging cutting-edge technologies into personalised care, emphasising interdisciplinary approaches. To fulfil the burgeoning healthcare requirement, Saudi Arabia is investing $500 billion to build an integrated megaproject region, NEOM, to create a human-centric care model through innovative systems, policies and infrastructure marvels. NEOM is forging to become a global benchmark for innovative technology, research, and education ...

Disruptive Technologies and New Industry Initiatives for Diabetes Management

Asia will continue to be a large and rapidly growing market for diabetes care technologies. To be competitive and successful in the aggressive market with numerous large and startup companies, players will need large funds, a broad portfolio with desirable differentiators and a strong distribution network. Low-cost products, subscription-based solutions, reimbursement policies and training of patients and physicians will be required to promote the adoption among low income and middle-income regi...

Roche Acquires Telavant and TL1A Antibody for Inflammatory Bowel Disease

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive agreement to acquire Telavant Holdings, Inc. (Telavant), a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc....

Roche's Fenebrutinib Shows Brain Penetration and Lesion Reduction in Multiple Sclerosis Patients: Late-breaking Data

Roche announced new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces brain lesions in people with relapsing multiple sclerosis (RMS) with a consistent safety profile to other fenebrutinib trials. The late-breaking data were featured in an oral presentation at the 9th Joint ECTRIMS-ACTRIMS Meeting (European and Americas Committees for Treatment and Research in Multiple Sclerosis)....

 Is It That Time of Year for Seasonal Infections? Exploring the Seasonal Patterns of Common Illnesses

As the leaves turn golden and temperatures begin to drop, many of us start to wonder: is it that time of year for seasonal infections? The changing seasons have long been associated with an uptick in certain illnesses, leaving us to ponder the reasons behind these patterns and how best to protect ourselves. In this article, we will delve into the world of seasonal infections, explore the science behind them, and offer practical advice for staying healthy during these trying times....

Lunit AI Poised to Replace One Human Reader in Breast Cancer Screening, Study Validates

- Lunit's collaborative study supports AI as a viable alternative to one human reader in Europe's double reading system - published in The Lancet Digital Health...